Photo of Richard Blumenthal
D United States Senate · Connecticut

Sen. Richard Blumenthal

Compare
Total votes
1,054
all sessions
Attendance
100%
1 missed
Higher than 82% of chamber peers
With party
97%
of cast votes
Near the chamber average
Bipartisan score
2%
crosses aisle rarely
Near the chamber average
Sponsored
2,861
bills & resolutions
Higher than 99% of chamber peers
Committees
14
assignments
2,861 bills and resolutions

Sponsored bills

Total
2,861
Primary
330
Co-sponsor
2,531
This page
2,861
matching current filters
Co-sponsor S 412
Passed · United States Senate · Co-sponsor
SHIELD Act of 2023

Maddy summaryS 412, the SHIELD Act of 2023, creates a federal criminal offense for knowingly distributing non-consensual intimate visual depictions (such as photos or videos of someone without their consent) or visual depictions of nude minors. It directly affects individuals who distribute such content without consent, including those sharing intimate images of adults or nude photos of minors, with penalties including up to 5 years in prison and asset forfeiture. Key provisions define "intimate visual depictions" (showing genitals or engaging in sexual conduct without consent), exclude law enforcement activities and legal reporting from the ban, and require forfeiture of materials used to distribute such content. The bill aims to address non-consensual image sharing and child sexual abuse material through federal criminal penalties.

Passed Jul 15, 2024 1 co-sponsor
Co-sponsor S 150
Passed · United States Senate · Co-sponsor
Affordable Prescriptions for Patients Act of 2023

Maddy summaryThe Affordable Prescriptions for Patients Act of 2023 targets "product hopping" by pharmaceutical manufacturers, which occurs when companies discontinue an original drug to make way for a follow-on product and prevent competition from cheaper generics or biosimilars. The bill prohibits two types of anti-competitive conduct: "hard switches" (discontinuing a drug or withdrawing approval) and "soft switches" (taking actions to disadvantage the original drug relative to a follow-on product). It gives the Federal Trade Commission authority to enforce these rules, including seeking remedies like disgorgement of profits from anti-competitive behavior. This legislation directly affects drug manufacturers, particularly those producing reference drugs and follow-on products, with the goal of increasing competition in the pharmaceutical market and lowering prescription costs.

Passed Jul 15, 2024 1 co-sponsor
Co-sponsor SRES 765
Passed · United States Senate · Co-sponsor
A resolution relating to the death of the Honorable James Mountain Inhofe, former Senator for the State of Oklahoma.

Maddy summarySRES 765 is a Senate resolution honoring the late Senator James M. Inhofe of Oklahoma following his death on July 9, 2024. The resolution commemorates his 28-year Senate service (1994-2023) and 52 years in public office, highlighting his work on defense policy, aviation legislation, infrastructure projects, and support for military bases in Oklahoma. This procedural resolution expresses the Senate's condolences and formally recognizes his legacy, rather than enacting any policy changes.

Passed Jul 12, 2024 1 co-sponsor
Co-sponsor S 138
Signed into law · United States Senate · Co-sponsor
Promoting a Resolution to the Tibet-China Dispute Act

Maddy summaryThe "Promoting a Resolution to the Tibet-China Dispute Act" amends the Tibetan Policy Act of 2002 to clarify US policy regarding Tibet. It directs the US Special Coordinator for Tibetan Issues to counter Chinese disinformation about Tibet's history, culture, and institutions, including claims that Tibet has been part of China since ancient times. The bill specifically defines Tibetan Autonomous Regions for policy purposes and authorizes funds to support these counter-disinformation efforts. It reaffirms that Tibet has a distinct cultural identity and that dialogue between China and Tibetan representatives should occur without preconditions. The bill does not change US diplomatic relations with China but provides specific guidance for US policy implementation.

Signed into law Jul 12, 2024 1 co-sponsor
Co-sponsor S 4671
In committee · United States Senate · Co-sponsor
Capping Prescription Costs Act of 2024

Maddy summaryThe Capping Prescription Costs Act of 2024 sets a yearly limit on out-of-pocket costs for prescription drugs under most health insurance plans. Starting in 2026, individual plan members would pay no more than $2,000 annually for covered drugs, while families would pay no more than $4,000. These limits would increase each year based on inflation, adjusted using the medical care component of the Consumer Price Index. The bill applies to both individual health plans and employer-sponsored group plans covered under the Affordable Care Act. It takes effect for plans beginning after December 2025.

In committee Jul 11, 2024 1 co-sponsor
Co-sponsor S 4680
In committee · United States Senate · Co-sponsor
Secretary General Jens Stoltenberg Congressional Gold Medal Act

Maddy summaryThis bill authorizes Congress to award a single Congressional Gold Medal to Jens Stoltenberg, former Secretary General of NATO, recognizing his leadership during his nine-year tenure. It directs the Treasury to strike the medal and allows for the sale of bronze duplicates to cover costs. The medal honors Stoltenberg's role in strengthening NATO's defense spending, enlargement, and unity - particularly during Russia's invasion of Ukraine - though the bill itself creates no new policy or obligations. The award is purely ceremonial and affects only Stoltenberg as the recipient.

In committee Jul 11, 2024 1 co-sponsor
Co-sponsor S 4691
In committee · United States Senate · Co-sponsor
No Tax Breaks for Drug Ads Act

Maddy summaryThis bill, S 4691 (No Tax Breaks for Drug Ads Act), removes a tax deduction for pharmaceutical companies that spend on direct-to-consumer advertising of prescription drugs. It directly affects drug manufacturers by eliminating the ability to deduct expenses for ads targeting the general public through TV, radio, print, online, or social media platforms. The key provision prohibits tax deductions for all such advertising costs starting after the bill's enactment date, without changing advertising rules or banning ads. This is a concrete tax policy change affecting pharmaceutical industry spending, not a regulatory measure.

In committee Jul 11, 2024 1 co-sponsor
Primary S 4699
In committee · United States Senate · Lead sponsor
Insurrection Act of 2024

Maddy summaryThis bill, the Insurrection Act of 2024, updates the legal framework for using military forces domestically to address insurrections, rebellions, or widespread violence. It requires the President to seek assistance from state or local authorities first, obtain a state official's request, and issue a public proclamation ordering lawbreakers to disperse before deploying troops. The bill establishes a strict 7-day limit for military deployment without congressional approval, requiring Congress to pass a joint resolution to extend it for up to 14 days. It also includes specific protections for voting rights, mandates detailed reporting to Congress, and allows judicial review of military deployments within 30 days. The bill directly affects the President's authority, Congress's oversight role, and state/local governments' ability to request federal military assistance.

In committee Jul 11, 2024 0 co-sponsors
Co-sponsor S 4706
In committee · United States Senate · Co-sponsor
Federal Firearm Licensee Act

Maddy summaryThe Federal Firearm Licensee Act would significantly strengthen regulations for federally licensed firearm dealers, manufacturers, and importers. Key provisions require dealers to implement physical security plans for their premises, conduct regular inventory checks of firearms, and maintain electronic records of all firearm transactions. The bill repeals restrictions that limited law enforcement's access to crime firearm trace data and increases penalties for violations, including civil fines and license suspensions. It also mandates background checks for dealer employees and expands reporting requirements for multiple firearm sales. This legislation directly affects all federally licensed firearm businesses operating under Chapter 44 of Title 18.

In committee Jul 11, 2024 1 co-sponsor
Co-sponsor S 4723
In committee · United States Senate · Co-sponsor
Keep Families Together Act

Maddy summaryThe Keep Families Together Act (S 4723) limits the separation of children from parents or legal guardians at or near the U.S. border or within 100 miles of it. It prohibits separation solely to deter migration or enforce immigration laws, allowing separation only under specific conditions: a state court order, a child welfare agency’s safety determination, or documented findings by border officials regarding trafficking, parentage, or immediate danger to the child. The bill requires agencies to document separations, provide monthly updates to families on children’s well-being, develop a public system for locating separated children, and mandate training for border agents on child welfare and trauma. It directly affects children under 18 without permanent U.S. immigration status and their families, applying to border enforcement agencies like Customs and Border Protection.

In committee Jul 11, 2024 1 co-sponsor
Showing 1,101 to 1,110 of 2,861 bills